Lipohypertrophy: Understanding Injection-Related Fatty Lumps

Oct 10

7 min read

Updated: 3 days ago

Medically reviewed by Dr. Baraa Alnahhal, MD · Last reviewed: October 17, 2026

Lipohypertrophy is a common condition in which lumps of fatty tissue develop under the skin because of repeated injections in the same place. It is frequently seen in people with diabetes, and the lumps can interfere with how the body absorbs medication such as insulin, leading to unpredictable blood sugar levels. Preventing it means rotating injection sites, using a fresh needle for every injection, and inspecting the skin regularly [1].

Quick Answer: What is lipohypertrophy?

Lipohypertrophy is a buildup of thickened, fatty or rubbery tissue under the skin caused by frequent injections or infusions in the same spot, affecting as many as 64% of people with diabetes. Insulin injected there may be absorbed unpredictably, causing blood sugar swings. Treatment means avoiding the area for at least two to three months and rotating sites. [1]

What the research says

Poor site rotation and needle reuse are the strongest modifiable risk factors. A meta-analysis of 51 studies in people with insulin-treated diabetes found that incorrect injection-site rotation had the strongest association with lipohypertrophy (prevalence odds ratio 8.85, 95% CI 5.10 to 15.33), followed by needle reuse (3.20, 95% CI 1.99 to 5.13) (Mader et al., J Diabetes Sci Technol, 2025 [2]).
Lipohypertrophy is linked to worse blood sugar control. In a meta-analysis of 37 studies, people with lipohypertrophy were more likely to have unexplained hypoglycemia (odds ratio 6.98, 95% CI 3.30 to 14.77) and glycemic variability (5.24, 95% CI 2.68 to 10.23), had HbA1c levels 0.55 percentage points higher (95% CI 0.23 to 0.87), and used 7.68 more insulin units per day (95% CI 5.31 to 10.06) (Mader et al., Diabetes Technol Ther, 2024 [3]).
The lumps are very common when looked for with ultrasound. A meta-analysis of 18 studies (7,139 patients receiving insulin injections) found that 70.5% had lipohypertrophy detected by ultrasound, and the authors call for routine screening, patient education, and regular follow-up (Zhang et al., BMC Public Health, 2026 [4]).

What is Lipohypertrophy?

Lipohypertrophy is the development of abnormal fatty lumps under the surface of the skin [1]. It results directly from repeated mechanical trauma to one area of tissue, most often from frequent medication injections or from an insulin pump cannula. It can affect anyone who receives regular injections, but it is most often documented in people who manage diabetes, and it can also affect people who need medication injections for HIV.

The lumps are made of a combination of enlarged fat cells, protein deposits, and scar tissue, and the fat cells in these areas can be about twice the size of normal fat cells. Because the lumps are often numb or partly numb, many people keep using them for injections to avoid pain, which unfortunately makes the condition worse [1].

What are the symptoms of lipohypertrophy?

Lipohypertrophy most commonly appears on the abdomen and thighs, the usual sites for insulin delivery, and the lumps can range from the size of a golf ball to a fist [1].

Physical Characteristics

Spotting these lumps early is essential for preventing long-term problems. The table below summarizes the common features.

Side-by-side skin cross-sections: healthy layers of skin and fat on the left, and on the right a raised lump of enlarged fatty tissue under the skin (lipohypertrophy). – rinnit.com

Healthy tissue (left) compared with a lump of enlarged fatty tissue under the skin (right).

Feature	Description
Texture	The area feels firmer, harder, or more rubbery than the surrounding healthy skin.
Appearance	Lumps may look raised, swollen, or uneven compared with the rest of the injection site.
Sensation	The affected area often has reduced feeling or may be completely numb to the touch.
Persistence	Lumps do not spread to other parts of the body but can grow larger if injections continue in that spot.

How does lipohypertrophy affect medication absorption?

The most important clinical concern is how lipohypertrophy interferes with the way the body handles medication [1]. When insulin or another drug is injected into thickened, fatty tissue, the absorption rate becomes unpredictable. This can lead to:

Hyperglycemia: Unexplained high blood sugar, for example when insulin is absorbed more slowly than expected.
Hypoglycemia: Sudden, dangerous drops in blood sugar, for example when insulin is absorbed more quickly than expected.
Diabetic ketoacidosis (DKA): A potentially life-threatening complication of diabetes.
Higher dose requirements: A need for more insulin to get the same effect.
Elevated A1c levels: Poorer overall blood sugar control, as shown on long-term testing.

What causes lipohypertrophy and who is at risk?

Lipohypertrophy occurs when insulin or another medication is injected into the same patch of skin too many times, including through an insulin pump infusion set [1]. Reusing needles is a major contributor, because a needle becomes dull and damaged after a single use and causes more trauma on re-entry.

Other risk factors include a low body mass index (BMI), which leaves less fat tissue for injections, and the use of human insulin instead of analog insulin. A disciplined rotation schedule is the best way to lower these risks [1].

Illustration of an abdomen divided into four quadrants with evenly spaced dots marking injection sites to rotate between. – rinnit.com

A rotation map for the abdomen: use a different spot each time.

How is lipohypertrophy diagnosed and managed?

Healthcare providers can usually diagnose lipohypertrophy by looking at the lump, pressing on the area, and talking with you about your injection and pump site habits. You can also check for it yourself by inspecting and feeling your skin regularly, especially before you insert a needle or pump cannula [1].

Treatment and Healing

There is no specific treatment for lipohypertrophy. You should stop injecting into the affected area for at least two to three months, until it heals and returns to normal. Healing often takes months and sometimes years, and nothing should be injected into the area until it has healed. For severe fat deposits, or lumps that do not resolve or are bothersome, a surgical procedure such as liposuction may be considered [1].

How can you prevent lipohypertrophy?

Lipohypertrophy is best prevented by rotating and spacing injection sites, changing pump sites often, using a fresh needle every time and tracking where you inject. These steps help keep the skin healthy and medication absorption consistent [1]:

Rotate sites: Change injection sites each time, and never inject into the exact same spot twice in a row.
Space injections: Keep each injection at least one finger width from the previous one (three finger widths for pump sites).
Change pump sites: Move insulin pump infusion sites to a new location every two to three days.
Use single-use needles: Use a fresh, sharp needle for every injection to limit tissue trauma.
Map your sites: Use a chart, calendar, or app to track where you have injected so you complete a full rotation.
Get your sites checked: Ask your provider to inspect your injection or pump sites at each in-person visit.

Illustration of a single-use needle with its cap beside a body diagram showing injection areas on the arms, abdomen, and thighs with circular arrows indicating rotation. – rinnit.com

A fresh needle for every injection and a planned rotation across injection areas.

When should you contact a healthcare provider about lipohypertrophy?

Lipohypertrophic skin should not be hot or warm to the touch, red, bruised, or painful. If an injection site shows any of these signs, seek medical attention, as it could be an infection or another problem. Also talk with your provider about any skin irregularities, especially if you are having trouble controlling your blood sugar [1].

Frequently Asked Questions

What is lipohypertrophy?

Lipohypertrophy is a lump of fatty tissue that develops under the skin due to repeated injections in the same location.

Why are these lumps common in people with diabetes?

Because diabetes often requires multiple daily insulin injections, the risk of repeated tissue trauma in the same area is very high.

Can I still inject into a fatty lump if it doesn't hurt?

No. Injecting into these lumps interferes with medication absorption and can lead to dangerous blood sugar fluctuations.

How long does it take for lipohypertrophy to go away?

It typically takes several months of avoiding the area for it to heal, though some cases may take years.

Does reusing needles cause these lumps?

Yes. Reusing needles causes more tissue damage because the needle tip becomes dull and jagged after the first use.

What does a lipohypertrophy lump feel like?

A lipohypertrophy lump usually feels firm, rubbery, or lumpy, and it may be raised or swollen compared to the surrounding skin.

Where do these lumps usually appear?

Lipohypertrophy lumps most commonly occur on the abdomen (belly) and the thighs, which are frequent sites for insulin injections.

Is lipohypertrophy dangerous?

The lumps themselves are not usually dangerous, but the resulting unpredictable medication absorption can cause life-threatening complications like DKA.

How can I tell the difference between a lump and an infection?

A lipohypertrophy lump is usually numb and not painful, whereas an infection will feel hot, look red, and may be painful or bruised.

Can surgery remove these lumps?

In severe cases that do not resolve on their own, liposuction or surgical removal may be an option.

References

Cleveland Clinic. Lipohypertrophy. Cleveland Clinic. April 29, 2022. https://my.clevelandclinic.org/health/diseases/22928-lipohypertrophy
Mader JK, Fornengo R, Hassoun A, et al. Risk factors for lipohypertrophy in people with insulin-treated diabetes: a systematic meta-analysis. Journal of Diabetes Science and Technology. 2025;20(4):1342-1352. PMID 40109173. https://doi.org/10.1177/19322968251325569
Mader JK, Fornengo R, Hassoun A, et al. Relationship between lipohypertrophy, glycemic control, and insulin dosing: a systematic meta-analysis. Diabetes Technology & Therapeutics. 2024;26(5):351-362. PMID 38215209. https://doi.org/10.1089/dia.2023.0491
Zhang Q, Zhu Y, Wang L, et al. Prevalence of insulin injection-induced lipohypertrophy detected by ultrasound: a systematic review and meta-analysis. BMC Public Health. 2026;26(1):663. PMID 41593584. https://doi.org/10.1186/s12889-026-26332-5

Medical disclaimer

This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.